spacer
spacer

PDBsum entry 5hhw

Go to PDB code: 
protein ligands links
Transferase PDB id
5hhw

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
306 a.a.
Ligands
60O
EDO
Waters ×320
PDB id:
5hhw
Name: Transferase
Title: Crystal structure of insulin receptor kinase domain in complex with cis-(r)-7-(3-(azetidin-1-ylmethyl)cyclobutyl)-5-(3-((tetrahydro-2h- pyran-2-yl)methoxy)phenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine.
Structure: Insulin receptor. Chain: a. Fragment: kinase domain, residues 1005-1310. Synonym: ir. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: insr. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108
Resolution:
1.79Å     R-factor:   0.172     R-free:   0.198
Authors: C.Scheufler,A.Izaac,F.Stauffer
Key ref: F.Stauffer et al. (2016). Identification of a 5-[3-phenyl-(2-cyclic-ether)-methylether]-4-aminopyrrolo[2,3-d]pyrimidine series of IGF-1R inhibitors. Bioorg Med Chem Lett, 26, 2065-2067. PubMed id: 26951750 DOI: 10.1016/j.bmcl.2016.02.074
Date:
11-Jan-16     Release date:   13-Apr-16    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P06213  (INSR_HUMAN) -  Insulin receptor from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1382 a.a.
306 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.2.7.10.1  - receptor protein-tyrosine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
L-tyrosyl-[protein]
+ ATP
= O-phospho-L-tyrosyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1016/j.bmcl.2016.02.074 Bioorg Med Chem Lett 26:2065-2067 (2016)
PubMed id: 26951750  
 
 
Identification of a 5-[3-phenyl-(2-cyclic-ether)-methylether]-4-aminopyrrolo[2,3-d]pyrimidine series of IGF-1R inhibitors.
F.Stauffer, S.W.Cowan-Jacob, C.Scheufler, P.Furet.
 
  ABSTRACT  
 
We report structure-guided modifications of the benzyloxy substituent of the Insulin-like Growth Factor-1 Receptor (IGF-1R) inhibitor NVP-AEW541. This chemical group has been shown to confer selectivity against other protein kinases but at the expense of a metabolism liability. X-ray crystallography has revealed that the benzyloxy moiety interacts with a lysine cation of the IGF-1R kinase domain via its ether function and its aromatic π-system and is nicely embedded in an induced hydrophobic pocket. We show that 1,4-diethers displaying an adequate hydrophobic and constrained shape are advantageous benzyloxy replacements. A single digit nanomolar inhibitor (compound 20, IC50=8.9nM) was identified following this approach.
 

 

spacer

spacer